Wesley Peace, MD
Physical Medicine & Rehabilitation · Nashville, TNNPI 1932594702
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 353 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Abbott accounts for 64.2% of it on its own, with 26 other manufacturers making up the rest. Among physical medicine & rehabilitation clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 353 payments — averaging $25.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$6K
- Boston Scientific$2K
- Nevro Corp.$389
- SPR Therapeutics, Inc$238
- Collegium Pharmaceutical, Inc.$155
- Relievant Medsystems, Inc.$91
- plus $597 from 21 others
What the payments were for
- Food & beverage$8,900100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 183 | $5,713 |
| Boston Scientific | 105 | $1,717 |
| Nevro Corp. | 17 | $389 |
| SPR Therapeutics, Inc | 4 | $238 |
| Collegium Pharmaceutical, Inc. | 9 | $155 |
| Relievant Medsystems, Inc. | 2 | $91 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $85 |
| Ipsen Biopharmaceuticals, Inc | 1 | $63 |
| Curonix LLC | 3 | $60 |
| AbbVie | 2 | $44 |
| Scilex Pharmaceuticals Inc. | 2 | $41 |
| Lilly USA, LLC | 2 | $33 |
| Pfizer | 2 | $30 |
| Vertex | 1 | $28 |
| Pacira Therapeutics, Inc. | 2 | $27 |
| Saluda Medical Americas, Inc. | 1 | $25 |
| Nalu Medical, Inc. | 1 | $23 |
| Medtronic | 1 | $21 |
| Stimwave Technologies Incorporated | 1 | $20 |
| Protega Pharmaceutials Inc | 1 | $19 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
| Virtus Pharmaceuticals LLC | 1 | $14 |
| Radius Health, Inc. | 1 | $13 |
| Siemens Medical Solutions USA, Inc. | 1 | $12 |
| IBSA Pharma Inc. | 1 | $11 |
| Zyla Life Sciences, Inc. | 1 | $11 |
| Kinex Medical Company LLC | 1 | $3 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROCLAIM$2,606
- WaveWriter Alpha Prime 16$240
- Proclaim IPG$121
- Senza$106
- SPRINT PNS System$104
- Axium$100
How this compares
$8,900 in reported general payments places this provider in the 95th percentile of 134 physical medicine & rehabilitation providers in Tennessee.
See all physical medicine & rehabilitation providers in Tennessee →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 726 | $22,238 |
| LinzessLinaclotide | 28 | $18,040 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 590 | $16,112 |
| Xtampza ErOxycodone Myristate | 32 | $14,903 |
| Lidocaine | 125 | $7,446 |
| Gabapentin | 623 | $6,957 |
| Oxycodone Hcl | 322 | $6,533 |
| MovantikNaloxegol Oxalate | 14 | $5,696 |
| Tizanidine Hcl | 326 | $4,654 |
| Diclofenac Sodium | 84 | $4,506 |
| Fentanyl | 28 | $3,876 |
| Pregabalin | 185 | $3,724 |
| Methocarbamol | 121 | $1,938 |
| Cyclobenzaprine Hcl | 165 | $1,745 |
| Morphine Sulfate ErMorphine Sulfate | 67 | $1,405 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLinzess | $44 | $18,04028 claims |
| Collegium Pharmaceutical, Inc.Xtampza Er | $155 | $14,90332 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 134 physical medicine & rehabilitation providers in Tennessee.
Other physical medicine & rehabilitation in Nashville
- Sandra GolamcoNashville$13K
- Heidi ChenNashville$5K
- Jeffery JohnsNashville$5K
- Rafael PrietoNashville$4K
- William SullivanNashville$4K
- David KennedyNashville$2K
- Ashley EavesNashville$1K
- Scott MillerNashville$1K
- Saumya AujlaNashville$1K
- Matthew MichaelsNashville$878
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.